| | The United States has administered 416,154,424 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 507,637,305 doses, the U.S. Centers for Disease Control and Prevention said. | | | An advisory panel of the U.S. Centers for Disease Control and Prevention will meet on Nov. 2 to discuss the use of COVID-19 vaccines in children aged between 5 and 11 years. | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. | | | U.S. states have placed initial orders of COVID-19 vaccines for children and millions of doses will be shipped as soon as health regulators authorize their use, the White House said on Wednesday. | | | Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18. | | | Singapore's health ministry reported 5,324 new cases of COVID-19 on Wednesday, the highest since the beginning of the pandemic, while it recorded 10 new deaths from the disease. | | | COVID-19 is slowly retreating across most of North, Central and South America, the Pan American Health Organization (PAHO) said on Wednesday, reporting that last week the continent's death and infection figures were the lowest in over a year. | | | Cases and deaths from COVID-19 among workers at the leading U.S. meatpacking plants were three times as high as previously estimated, according to a report by the House Select Subcommittee on the Coronavirus Crisis seen by Reuters. | | | Sweden will start offering COVID-19 booster shots to people aged 65 or older as well as many care workers and plans to gradually extend the third jabs to most Swedes in the coming months, the government said on Wednesday. | | | Novavax Inc said on Wednesday it had completed the real-time submission of an application for the authorization of its COVID-19 vaccine candidate in the United Kingdom. | | | | |